Premarket Mover: Phio Pharmaceuticals Corp (PHIO) Down 12.67%

Friday, May 19, 2023 06:55 AM | InvestorsObserver Analysts

Mentioned in this article

Phio Pharmaceuticals Corp (PHIO) has fallen Friday morning, with the stock falling -12.67% in pre-market trading to 4.41. PHIO's short-term technical score of 49 indicates that the stock has traded less bullishly over the last month than 51% of stocks on the market. In the Biotechnology industry, which ranks 87 out of 146 industries, the stock ranks higher than 56% of stocks. Phio Pharmaceuticals Corp has risen 2.85% over the past month, closing at $3.85 on April 21. During this period of time, the stock fell as low as $3.23 and as high as $4.92. PHIO has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.

PHIO has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on PHIO!
Phio Pharmaceuticals Corp has a Long-Term Technical rank of 66. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 34% of the market scoring higher. In the Biotechnology industry which is number 89 by this metric, PHIO ranks better than 89% of stocks.

Important Dates for Investors in PHIO:

-Phio Pharmaceuticals Corp is set to release earnings on 8/9/2023. Over the last 12 months, the company has reported EPS of $-3.15. -We do not have a set dividend date for Phio Pharmaceuticals Corp at this time. Click Here To Get The Full Report on Phio Pharmaceuticals Corp (PHIO)

Share this article: